Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.

Preserved brain functional plasticity after upper limb task-oriented rehabilitation in progressive multiple sclerosis.

Boffa G, Tacchino A, Sbragia E, Schiavi S, Droby A, Piaggio N, Bommarito G, Girardi G, Mancardi GL, Brichetto G, Inglese M.

Eur J Neurol. 2019 Aug 16. doi: 10.1111/ene.14059. [Epub ahead of print]

PMID:
31419353
2.

A two alternative forced choice method for assessing vibrotactile discrimination thresholds in the lower limb.

Iandolo R, Carè M, Shah VA, Schiavi S, Bommarito G, Boffa G, Giannoni P, Inglese M, Mrotek LA, Scheidt RA, Casadio M.

Somatosens Mot Res. 2019 Jun;36(2):162-170. doi: 10.1080/08990220.2019.1632184. Epub 2019 Jul 3.

PMID:
31267810
3.

Could arterial spin labelling perfusion imaging uncover the invisible in N-methyl-d-aspartate receptor encephalitis?

Lapucci C, Boffa G, Massa F, Franciotta D, Castelletti L, Uccelli A, Morbelli S, Nobili F, Benedetti L, Roccatagliata L.

Eur J Neurol. 2019 May 17. doi: 10.1111/ene.13977. [Epub ahead of print] No abstract available.

PMID:
31099961
4.

Two-way crossed cerebellar diaschisis in a clinically isolated syndrome suggestive of multiple sclerosis.

Boffa G, Lapucci C, Morbelli SD, Nobili FM.

Q J Nucl Med Mol Imaging. 2019 May 8. doi: 10.23736/S1824-4785.19.03171-6. [Epub ahead of print]

PMID:
31089076
5.

Different MRI patterns in MS worsening after stopping fingolimod.

Lapucci C, Baroncini D, Cellerino M, Boffa G, Callegari I, Pardini M, Novi G, Sormani MP, Mancardi GL, Ghezzi A, Zaffaroni M, Uccelli A, Inglese M, Roccatagliata L.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 16;6(4):e566. doi: 10.1212/NXI.0000000000000566. eCollection 2019 Jul.

6.

Fronto-temporal vulnerability to disconnection in paediatric moderate and severe traumatic brain injury.

Molteni E, Pagani E, Strazzer S, Arrigoni F, Beretta E, Boffa G, Galbiati S, Filippi M, Rocca MA.

Eur J Neurol. 2019 Sep;26(9):1183-1190. doi: 10.1111/ene.13963. Epub 2019 May 6.

PMID:
30964589
7.

Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis.

Mancardi G, Sormani MP, Muraro PA, Boffa G, Saccardi R.

Mult Scler. 2018 Mar;24(3):245-255. doi: 10.1177/1352458517742532. Epub 2017 Nov 10. Review.

8.

A diffusion tensor magnetic resonance imaging study of paediatric patients with severe non-traumatic brain injury.

Molteni E, Rocca MA, Strazzer S, Pagani E, Colombo K, Arrigoni F, Boffa G, Copetti M, Pastore V, Filippi M.

Dev Med Child Neurol. 2017 Feb;59(2):199-206. doi: 10.1111/dmcn.13332. Epub 2016 Dec 2.

9.

Direct Synthesis of Telechelic Polyethylene by Selective Insertion Polymerization.

Jian Z, Falivene L, Boffa G, Sánchez SO, Caporaso L, Grassi A, Mecking S.

Angew Chem Int Ed Engl. 2016 Nov 7;55(46):14378-14383. doi: 10.1002/anie.201607754. Epub 2016 Oct 13.

PMID:
27736020
10.

In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis.

Rocca MA, Longoni G, Pagani E, Boffa G, Colombo B, Rodegher M, Martino G, Falini A, Comi G, Filippi M.

Hum Brain Mapp. 2015 Nov;36(11):4702-13. doi: 10.1002/hbm.22946. Epub 2015 Aug 19.

PMID:
26287572
11.

Pharmacokinetics of pentoxifylline and its main metabolites in patients with different degrees of heart failure following a single dose of a modified-release formulation.

Nisi A, Panfili M, De Rosa G, Boffa G, Groppa F, Gusella M, Padrini R.

J Clin Pharmacol. 2013 Jan;53(1):51-7. doi: 10.1177/0091270011433435. Epub 2013 Jan 24.

PMID:
23400743
12.

Pharmacological treatment of chronic systolic heart failure: are we scraping the bottom of the barrel?

Boffa GM.

J Cardiovasc Med (Hagerstown). 2011 Jun;12(6):452. doi: 10.2459/JCM.0b013e32834699f5. No abstract available.

PMID:
21540677
13.

In-hospital management of heart failure: in 10 years we have improved, but not enough.

Ferretto S, Dalla Valle C, Cukon Buttignoni S, Brugnaro L, Boffa GM.

Intern Emerg Med. 2011 Jun;6(3):235-9. doi: 10.1007/s11739-010-0493-3. Epub 2010 Dec 9.

PMID:
21152996
14.

HPLC determination of plasma dimethylarginines: method validation and preliminary clinical application.

Ivanova M, Artusi C, Boffa GM, Zaninotto M, Plebani M.

Clin Chim Acta. 2010 Nov 11;411(21-22):1632-6. doi: 10.1016/j.cca.2010.06.001. Epub 2010 Jun 11.

PMID:
20542018
15.

Pharmacological treatment of chronic systolic heart failure: are we scraping the bottom of the barrel?

Abate E, Sartor R, Ceconi C, Boffa GM.

J Cardiovasc Med (Hagerstown). 2010 Dec;11(12):893-905. doi: 10.2459/JCM.0b013e328339d884. Review.

PMID:
20414119
16.

Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide.

Boffa GM, Zaninotto M, Sartor R, Mion M, Berton A, Pasqualetto C, Razzolini R, Plebani M.

J Cardiovasc Med (Hagerstown). 2009 Oct;10(10):758-64. doi: 10.2459/JCM.0b013e32832ce8e2.

PMID:
19553828
17.

Renal dysfunction is a confounder for plasma natriuretic peptides in detecting heart dysfunction in uremic and idiopathic dilated cardiomyopathies.

Codognotto M, Piccoli A, Zaninotto M, Mion M, Plebani M, Vertolli U, Tona F, Ruzza L, Barchita A, Boffa GM.

Clin Chem. 2007 Dec;53(12):2097-104. Epub 2007 Oct 12.

18.

Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy.

Calore C, Cacciavillani L, Boffa GM, Silva C, Tiso E, Marra MP, Bacchiega E, Corbetti F, Iliceto S.

J Cardiovasc Med (Hagerstown). 2007 Oct;8(10):821-9.

PMID:
17885521
19.

Cystatin C in heart failure is nothing more than a bystander of glomerular filtration.

Codognotto M, Piccoli A, Zaninotto M, Mion M, Vertolli U, Tona F, Boffa GM.

J Nephrol. 2007 Mar-Apr;20(2):219-27.

PMID:
17514627
20.

Evidence for decreased circulating apelin beyond heart involvement in uremic cardiomyopathy.

Codognotto M, Piccoli A, Zaninotto M, Mion M, Vertolli U, Tona F, Boffa GM.

Am J Nephrol. 2007;27(1):1-6. Epub 2007 Jan 5.

PMID:
17204831
21.

Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.

Boffa GM, Zaninotto M, Bacchiega E, Nalli C, Forni M, Tiso E, Cacciavillani L, Razzolini R, Plebani M.

Ital Heart J. 2005 Feb;6(2):125-32.

PMID:
15819505
22.

Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.

Razzolini R, Tarantini G, Boffa GM, Orlando S, Iliceto S.

Ital Heart J. 2004 Jul;5(7):517-22.

PMID:
15487269
23.

Overexpression of tumor necrosis factor (TNF)alpha and TNFalpha receptor I in human viral myocarditis: clinicopathologic correlations.

Calabrese F, Carturan E, Chimenti C, Pieroni M, Agostini C, Angelini A, Crosato M, Valente M, Boffa GM, Frustaci A, Thiene G.

Mod Pathol. 2004 Sep;17(9):1108-18.

24.

Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure.

Boffa GM, Zaninotto M, Nalli C, Forni M, Tiso E, Razzolini R, Plebani M.

Ital Heart J. 2004 Jan;5(1):48-52.

PMID:
15080581
25.

Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications.

Calabrese F, Rigo E, Milanesi O, Boffa GM, Angelini A, Valente M, Thiene G.

Diagn Mol Pathol. 2002 Dec;11(4):212-21.

PMID:
12459637
26.

Active versus borderline myocarditis: clinicopathological correlates and prognostic implications.

Angelini A, Crosato M, Boffa GM, Calabrese F, Calzolari V, Chioin R, Daliento L, Thiene G.

Heart. 2002 Mar;87(3):210-5.

27.

Ischemic cardiomyopathy: lack of clinical applicability of the WHO/ISFC classification of cardiomyopathies.

Boffa GM, Tarantini G, Abbasciano A, Razzolini R, Chioin R, Thiene G.

Ital Heart J. 2001 Oct;2(10):778-81.

PMID:
11721723
28.

[Treatment of heart failure at a hospital in the north-east of Italy].

Buttignoni SC, Crosato M, Boffa GM.

Ann Ital Med Int. 2001 Jan-Mar;16(1):26-31. Italian.

PMID:
11688347
29.

Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis.

Angelini A, Calzolari V, Calabrese F, Boffa GM, Maddalena F, Chioin R, Thiene G.

Heart. 2000 Sep;84(3):245-50.

30.

Angiographic presentation of coronary artery spasm in heart transplant recipients.

Boffa GM, Livi U, Grassi G, Casarotto D, Isabella G, Cardaioli P, Panfili M, Chioin R.

Int J Cardiol. 2000 Mar 31;73(1):67-74.

PMID:
10748313
31.

Discordance between pre and post cardiac transplant diagnosis: implications for pre- and postoperative decision making.

Angelini A, Boffa GM, Livi U, Barchitta A, Casarotto D, Thiene G.

Cardiovasc Pathol. 1999 Jan-Feb;8(1):17-23.

PMID:
10722244
32.

Impact of organ preservation techniques on outcome of cardiac transplantation in the era of donor pool expansion.

Livi U, Caforio AL, Guzzi G, Feltrin G, Boffa GM, Angelini A, Casarotto D.

Transplant Proc. 1997 Dec;29(8):3382-3. No abstract available.

PMID:
9414757
33.

[Improvement of short-term prognosis in patients with refractory heart failure].

Boffa GM, Cannas S, Cacciavillani L, Marzari A, Grassi G, Bauce B, Livi U, Maddalena F.

G Ital Cardiol. 1997 Oct;27(10):1024-8. Italian.

PMID:
9410772
34.

Morphologic spectrum of primary restrictive cardiomyopathy.

Angelini A, Calzolari V, Thiene G, Boffa GM, Valente M, Daliento L, Basso C, Calabrese F, Razzolini R, Livi U, Chioin R.

Am J Cardiol. 1997 Oct 15;80(8):1046-50.

PMID:
9352976
35.

Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.

Caforio AL, Bauce B, Boffa GM, De Cian F, Angelini A, Melacini P, Razzolini R, Fasoli G, Chioin R, Schiaffino S, Thiene G, Dalla Volta S.

G Ital Cardiol. 1997 Feb;27(2):106-12.

PMID:
9199945
36.

[Lipid peroxidation and LDL modifications in nondiabetic patients with ischemic heart disease: the role of insulin action].

Avogaro A, Armigliato M, Cazzolato G, Caruso N, Boffa G, Bittolo Bon G, Tiengo A.

G Ital Cardiol. 1996 Feb;26(2):169-75. Italian.

PMID:
8666174
37.

Donor age greater than 50 years does not influence midterm results of heart transplantation.

Livi U, Caforio AL, Tursi V, Boffa GM, Borrelli MR, Bauce B, Thiene G, Casarotto D.

Transplant Proc. 1996 Feb;28(1):91-2. No abstract available.

PMID:
8644352
38.

[Analysis of risk factors in a group of patients referred for heart transplantation for refractory heart failure: multivariate analysis].

Maddalena F, Boffa GM, Cacciavillani L, Marzari A, Reimers B, Dalla Volta S.

G Ital Cardiol. 1995 Dec;25(12):1573-80. Italian.

PMID:
8707005
39.

[Guidelines for the indication for orthotopic heart transplantation. The Cardiologists and Heart Surgeons of the Heart Transplant Group of Nord Italy Transplant (NITp)].

Binetti G, Gavazzi A, Gronda E, Boffa GM, Albanese MC, Perini G.

G Ital Cardiol. 1995 Jun;25(6):737-44. Italian. No abstract available.

PMID:
7649423
40.

Heart transplantation for end-stage valvular disease.

Livi U, Caforio AL, Grassi G, Boffa GM, Barchitta A, Gambino A, Thiene G, Casarotto D.

Transplant Proc. 1995 Feb;27(1):1305-6. No abstract available.

PMID:
7878893
41.

Mid-term results of heart transplantation for end-stage valvular disease.

Livi U, Caforio AL, Boffa GM, Tursi V, Thiene G, Casarotto D.

Eur J Cardiothorac Surg. 1995;9(9):521-5.

PMID:
8800702
42.

Impressions of British anaesthesia.

Boffa GM.

Br J Anaesth. 1995 Jan;74(1):110. No abstract available.

43.

[Polycythemia secondary to pelvic leiomyosarcoma. Apropos of a case].

Mayet T, Lacoste D, Morlat P, Lifermann F, Bernard N, Boffa GA, Brun G, Beylot J, De Mascarel A.

Ann Med Interne (Paris). 1995;146(2):134-5. French. No abstract available.

PMID:
7598342
44.

Mid-term results of heart transplantation in diabetic patients.

Livi U, Caforio AL, Grassi G, Boffa GM, Gambino A, Milano A, Bianco R, Casula R, Thiene G, Casarotto D.

J Cardiovasc Surg (Torino). 1994 Dec;35(6 Suppl 1):115-8.

PMID:
7775522
45.

Influence of rejection on late graft function after heart transplantation.

Livi U, Milano A, Caforio AL, Grassi G, Feltrin G, Boffa GM, D'Agnolo A, Angelini A, Thiene G, Casarotto D.

Transplant Proc. 1994 Oct;26(5):2727-8. No abstract available.

PMID:
7940855
46.

Donor shortage in heart transplantation. Is extension of donor age limits justified?

Livi U, Bortolotti U, Luciani GB, Boffa GM, Milano A, Thiene G, Casarotto D.

J Thorac Cardiovasc Surg. 1994 May;107(5):1346-54; discussion 1354-5.

PMID:
8176979
47.

Pulmonary vascular resistance variation over time in candidates for heart transplantation.

Boffa GM, Razzolini R, Grassi G, Basso C, Ramondo A, Isabella G, Cardaioli P, Stritoni P, Daliento L, Chioin R.

Am J Cardiol. 1994 Feb 15;73(5):414-5. No abstract available.

PMID:
8109562
48.

Preparation and biological properties of monoclonal antibodies against human erythropoietin.

Ben Ghanem A, Pallu S, Winchenne JJ, Raymonjean N, Mayeux P, Goossens D, Boffa GA, Casadevall N, Cartron JP, Lambin P.

Hybridoma. 1993 Oct;12(5):599-608.

PMID:
8300136
49.

Endomyocardial biopsy in right ventricular cardiomyopathy.

Angelini A, Thiene G, Boffa GM, Calliari I, Daliento L, Valente M, Chioin R, Nava A, Volta SD, Calliaris I [corrected to Calliari I].

Int J Cardiol. 1993 Jul 15;40(3):273-82. Erratum in: Int J Cardiol 1993 Oct 1;41(3):246.

PMID:
8225662
50.

Clinical results of steroid-free induction immunosuppression after heart transplantation.

Livi U, Luciani GB, Boffa GM, Faggian G, Bortolotti U, Thiene G, Mazzucco A.

Ann Thorac Surg. 1993 May;55(5):1160-5.

PMID:
8494426

Supplemental Content

Support Center